Myocarditis and long-term survival in peripartum cardiomyopathy.

BACKGROUND The reported mortality rate of peripartum cardiomyopathy (PPCM) is high, although the potential for spontaneous recovery of ventricular function is well established. The prevalence of myocarditis in PPCM has varied widely between studies. The purposes of this study were to define the long-term prognosis in a referral population of patients with PPCM, to determine the prevalence of myocarditis on endomyocardial biopsy in this population, and to identify clinical variables associated with poor outcome. METHODS We analyzed clinical, echocardiographic, hemodynamic, and histologic features of 42 women with PPCM evaluated at our institution over a 15-year period. Each patient underwent an extensive evaluation, including echocardiography, endomyocardial biopsy, and right heart catheterization. Data were analyzed to identify features at initial examination associated with the combined end point of death or cardiac transplantation by the use of Kaplan-Meier survival curves and a Cox proportional hazards model. RESULTS Three (7%) patients died and 3 (7%) patients underwent heart transplantation during a median follow-up of 8.6 years. Endomyocardial biopsy demonstrated a high prevalence of myocarditis (62%), but the presence or absence of myocarditis was not associated with survival. Of the prespecified variables assessed, only decreased left ventricular stroke work index was associated with worsened outcome. CONCLUSIONS In patients with PPCM, (1) long-term survival is better than has been historically reported, (2) the prevalence of myocarditis is high, and (3) decreased left ventricular stroke work index is associated with worse clinical outcomes.

[1]  H. Aretz Myocarditis: the Dallas criteria. , 1987, Human pathology.

[2]  E. Olsen,et al.  Peripartum Cardiomyopathy Due to Myocarditis , 1982 .

[3]  J. A. Robinson,et al.  Peripartum cardiomyopathy: Clinical, hemodynamic, histologic and prognostic characteristics , 1986 .

[4]  J. Hsia,et al.  Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. , 2000, JAMA.

[5]  R H Hruban,et al.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.

[6]  D. Alexopoulos,et al.  Prognosis in peripartum cardiomyopathy. , 1989, The American journal of cardiology.

[7]  J. Sanderson,et al.  Peripartum heart disease: an endomyocardial biopsy study. , 1986, British heart journal.

[8]  G. Hutchins,et al.  Peripartum myocarditis and cardiomyopathy. , 1990, Circulation.

[9]  R. Kitsis,et al.  Peripartum versus idiopathic dilated cardiomyopathy in young women--a comparison of clinical, pathologic and prognostic features. , 1993, International journal of cardiology.

[10]  S. Rahimtoola,et al.  Natural Course of Peripartum Cardiomyopathy , 1971, Circulation.

[11]  B. Maciel,et al.  High output failure in patients with peripartum cardiomyopathy: a comparative study with dilated cardiomyopathy. , 1991, American heart journal.

[12]  D. Homans Current concepts: peripartum cardiomyopathy , 1985 .

[13]  M. G. St. John Sutton,et al.  Longitudinal changes in left ventricular architecture and function in peripartum cardiomyopathy. , 1987, The American journal of cardiology.

[14]  P. Rickenbacher,et al.  Incidence of myocarditis in peripartum cardiomyopathy. , 1994, The American journal of cardiology.

[15]  G. MacGowan,et al.  Intravenous immune globulin in the therapy of peripartum cardiomyopathy. , 1999, Journal of the American College of Cardiology.

[16]  D. Zaccaro,et al.  Peripartum cardiomyopathy: summary of an international survey on peripartum cardiomyopathy. , 1999, American journal of obstetrics and gynecology.